The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Hemagglutinating virus of Japan envelope (HVJ-E) is a replication-incompetent viral vector.
• HVJ-E has demonstrated selective apoptosis induction in cancer cells.
• The precise molecular mechanisms underlying this selective cell death are under investigation.

Purpose of the Study:

• To elucidate the molecular pathways by which HVJ-E induces apoptosis selectively in cancer cells.
• To identify the viral components and host cell receptors involved in this process.
• To understand the role of the RIG-I/MAVS signaling pathway in HVJ-E-mediated cancer cell apoptosis.

Main Methods:

• Utilized replication-incompetent hemagglutinating virus of Japan envelope (HVJ-E) as a delivery vector.
• Introduced viral RNA genome fragments into cancer cells via HVJ-E.
• Investigated the activation of retinoic acid-inducible gene I (RIG-I) and mitochondrial antiviral signaling (MAVS) pathways.
• Analyzed the expression of pro-apoptotic factors downstream of the RIG-I/MAVS pathway in cancer cells.

Main Results:

• Fragments of the HVJ-E RNA genome were successfully delivered into cancer cells.
• The delivered viral RNA fragments were recognized by RIG-I and MAVS.
• Activation of the RIG-I/MAVS pathway led to the selective upregulation of pro-apoptotic factors.
• This upregulation was specifically observed in cancer cells, confirming selective induction of apoptosis.

Conclusions:

• HVJ-E-mediated delivery of viral RNA fragments activates the RIG-I/MAVS innate immune pathway.
• This activation selectively upregulates pro-apoptotic factors in cancer cells, leading to targeted cell death.
• HVJ-E represents a promising platform for cancer therapy by exploiting cancer-specific vulnerabilities in innate immune signaling.